US Leaves WHO Over Pandemic, Governance - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

US Leaves WHO Over Pandemic, Governance

The announcement describes a shift toward direct engagement with countries and organizations outside the World Health Organization.

  • By

  • Kathryn Wighton

  • January 23, 2026

  • 3 min

Share

Clinical Scorecard: US Leaves WHO Over Pandemic, Governance

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationGlobal public health stakeholders and affected populations
Care Setting

Key Highlights

  • US completed withdrawal from WHO on January 22, 2026

Guideline-Based Recommendations

Diagnosis

    Management

    • Engage in bilateral partnerships for health initiatives
    • Implement reforms to address governance weaknesses

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Focus on emergency response and biosecurity coordination, with emphasis on public health governance

        Clinical Best Practices

        • Prioritize transparency and timely communication in health governance
        • Foster collaboration with diverse health stakeholders
        • Implement reforms to enhance organizational independence and effectiveness
        • Address misinformation and enhance global trust in health organizations

        Related Resources & Content

        Original Source(s)

        US Leaves WHO Over Pandemic, Governance

        • by Kathryn Wighton

        • January 23, 2026

        Related Content

        Neonatal HSV-1 diversity greater between patients than within patients

        Deep sequencing found no significant association between minor-variant burden and disease severity, although several newborns had unusually high within-host viral diversity.

        Top 10 evidence-based essentials in infectious disease

        A structured framework of guidelines, trials, therapies, and tools used in clinical practice

        FDA Monthly Preview: Key August Decisions to Watch

        Several FDA decisions across multiple specialties are expected this month.